Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Evens

Showing results (71-80 of 253) with videos related to

Pageof 26
Sort By:
Journal of Drugs in Dermatology : JDD|January 4, 2011
Diffuse large B-cell lymphoma associated with the use of biologic and other investigational agents: the importance of long-term post-marketing safety surveillanceAllison Goddard, Judy H Borovicka, Dennis P West, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 15, 2018
Microfluidic assembly of hydrogel-based immunogenic tumor spheroids for evaluation of anticancer therapies and biomarker releasePooja Sabhachandani, Saheli Sarkar, Seamus Mckenney, et al.
Blood|March 15, 2003
Expression of the candidate MCT-1 oncogene in B- and T-cell lymphoid malignanciesBo Shi, Hsin-Ling Hsu, Andy M Evens, et al.
Biomedicines|November 11, 2022
An Analysis of Transcriptomic Burden Identifies Biological Progression Roadmaps for Hematological Malignancies and Solid TumorsDashnamoorthy Ravi, Afshin Beheshti, Kristine Burgess, et al.
Current Oncology Reports|October 22, 2010
Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapyAndrew M Evens, Rupali Roy, Danielle Sterrenberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2014
Multiple successful desensitizations to brentuximab vedotin: a case report and literature reviewMichael D DeVita, Andrew M Evens, Steven T Rosen, et al.
Oncology (Williston Park, N.Y.)|July 31, 2010
Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic optionsChristiane Querfeld, Irum Khan, Brett Mahon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Imexon-induced apoptosis in multiple myeloma tumor cells is caspase-8 dependentAndrew M Evens, Sheila Prachand, Bo Shi, et al.
Clinical Lymphoma & Myeloma|September 19, 2007
Sustained hematologic and central nervous system remission with single-agent denileukin diftitox in refractory adult T-cell leukemia/lymphomaAndrew M Evens, Sheryl L Ziegler, Rohit Gupta, et al.
Blood|October 8, 2005
T-cell non-Hodgkin lymphomaMujahid A Rizvi, Andrew M Evens, Martin S Tallman, et al.
Pageof 26

Showing results (71-80 of 253) with videos related to

Sort By:
Pageof 26
Journal of Drugs in Dermatology : JDD|January 4, 2011
Diffuse large B-cell lymphoma associated with the use of biologic and other investigational agents: the importance of long-term post-marketing safety surveillanceAllison Goddard, Judy H Borovicka, Dennis P West, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 15, 2018
Microfluidic assembly of hydrogel-based immunogenic tumor spheroids for evaluation of anticancer therapies and biomarker releasePooja Sabhachandani, Saheli Sarkar, Seamus Mckenney, et al.
Blood|March 15, 2003
Expression of the candidate MCT-1 oncogene in B- and T-cell lymphoid malignanciesBo Shi, Hsin-Ling Hsu, Andy M Evens, et al.
Biomedicines|November 11, 2022
An Analysis of Transcriptomic Burden Identifies Biological Progression Roadmaps for Hematological Malignancies and Solid TumorsDashnamoorthy Ravi, Afshin Beheshti, Kristine Burgess, et al.
Current Oncology Reports|October 22, 2010
Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapyAndrew M Evens, Rupali Roy, Danielle Sterrenberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2014
Multiple successful desensitizations to brentuximab vedotin: a case report and literature reviewMichael D DeVita, Andrew M Evens, Steven T Rosen, et al.
Oncology (Williston Park, N.Y.)|July 31, 2010
Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic optionsChristiane Querfeld, Irum Khan, Brett Mahon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Imexon-induced apoptosis in multiple myeloma tumor cells is caspase-8 dependentAndrew M Evens, Sheila Prachand, Bo Shi, et al.
Clinical Lymphoma & Myeloma|September 19, 2007
Sustained hematologic and central nervous system remission with single-agent denileukin diftitox in refractory adult T-cell leukemia/lymphomaAndrew M Evens, Sheryl L Ziegler, Rohit Gupta, et al.
Blood|October 8, 2005
T-cell non-Hodgkin lymphomaMujahid A Rizvi, Andrew M Evens, Martin S Tallman, et al.
Pageof 26